Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, vol.235, issue.4785, pp.177-182, 1987. ,
DOI : 10.1126/science.3798106
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science, vol.244, issue.4905, pp.707-719, 1989. ,
DOI : 10.1126/science.2470152
Correlation between immunohistochemistry (HercepTest) and fluorescencein situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres, The Journal of Pathology, vol.94, issue.4, pp.418-441, 2003. ,
DOI : 10.1002/path.1313
Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis, Canadian Medical Association Journal, vol.176, issue.10, pp.1429-1463, 2007. ,
DOI : 10.1503/cmaj.061011
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer, New England Journal of Medicine, vol.353, issue.16, pp.1673-84, 2005. ,
DOI : 10.1056/NEJMoa052122
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer, New England Journal of Medicine, vol.353, issue.16, pp.1659-72, 2005. ,
DOI : 10.1056/NEJMoa052306
Current Perspectives on HER2 Testing: A Review of National Testing Guidelines, Modern Pathology, vol.16, issue.2, pp.173-82, 2003. ,
DOI : 10.1097/01.MP.0000052102.90815.82
HER-2 Testing in Breast Cancer Using Parallel Tissue-Based Methods, JAMA, vol.291, issue.16, pp.1972-1979, 2004. ,
DOI : 10.1001/jama.291.16.1972
Human Epidermal Growth Factor Receptor 2 Status Correlates With Lymph Node Involvement in Patients With Estrogen Receptor (ER) ???Negative, but With Grade in Those With ER-Positive Early-Stage Breast Cancer Suitable for Cytotoxic Chemotherapy, Journal of Clinical Oncology, vol.25, issue.28, pp.4423-4430, 2007. ,
DOI : 10.1200/JCO.2007.11.0973
Testing by Local, Central, and Reference Laboratories in Specimens From the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial, Journal of Clinical Oncology, vol.24, issue.19, pp.3032-3038, 2006. ,
DOI : 10.1200/JCO.2005.03.4744
Real-World Performance of HER2 Testing--National Surgical Adjuvant Breast and Bowel Project Experience, JNCI Journal of the National Cancer Institute, vol.94, issue.11, pp.852-854, 2002. ,
DOI : 10.1093/jnci/94.11.852